MYRX OTC
Myrexis, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +100.0%
1Y: -73.3%
3Y: -50.0%
5Y: -98.4%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.007
Volume50,000
Avg Volume12,474
Beta3.18
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJonathan Couchman
Employees1
SectorFinancial Services
IndustryShell Companies
IPO Date2009-06-12
Websitemyrexis.com
630 Fifth Avenue
New York City, NY 10020
US
New York City, NY 10020
US
801-214-7800
About Myrexis, Inc.
Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New York.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| COUCHMAN JONATHAN | 0 | — | 2013-01-22 | |
| HENDERSON JOHN T | M-Exempt | 2,500 | $0.95 | 2013-01-18 |
| HENDERSON JOHN T | M-Exempt | 7,500 | $2.55 | 2013-01-18 |
| HENDERSON JOHN T | M-Exempt | 7,500 | $1.65 | 2013-01-18 |
| HENDERSON JOHN T | M-Exempt | 7,500 | $1.18 | 2013-01-18 |